Kynam Capital Management »

Corcept Therapeutics Incorporated shares owned by Kynam Capital Management

Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Kynam Capital Management from 13F filings

Historical chart of Kynam Capital Management investment in Corcept Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Corcept Therapeutics Incorporated held by Kynam Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corcept Therapeutics Incorporated by Kynam Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $19M 586k 32.48

More positions owned by Kynam Capital Management

Natera (NTRA)
Syndax Pharmaceuticals (SNDX)
Celldex Therapeutics Com New (CLDX)
Vaxcyte (PCVX)
Vera Therapeutics Cl A (VERA)
Protagonist Therapeutics (PTGX)
ImmunoGen
Morphosys Sponsored Ads (MOR)
Cogent Biosciences (COGT)
Liquidia Corporation Com New (LQDA)
BioCryst Pharmaceuticals (BCRX)
2seventy Bio Common Stock (TSVT)
Dynavax Technologies Corp Com New (DVAX)
Wave Life Sciences SHS (WVE)
Corcept Therapeutics Incorporated Put Option (CORT)

View all positions for Kynam Capital Management

Top funds holding Corcept Therapeutics Incorporated

Vanguard Group
Ingalls & Snyder
Parallel Advisors
Dimensional Fund Advisors
Norden Group
Btim
Federated Investors
D. E. Shaw & Co
Arrowstreet Capital, Limited Partnership
Charles Schwab Investment Management
Man Group
Norges Bank Investment Management
Bank of New York Mellon
Millennium Management
Kynam Capital Management

View all funds holding Corcept Therapeutics Incorporated